南華早報Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge
作者 Yulu Ao
文章摘要
南華早報 · 文章頁摘要Strong demand for drug development drove the forecast, though the firm faces ongoing scrutiny from Washington.
原站閱讀
全文請至原站閱讀。
Strong demand for drug development drove the forecast, though the firm faces ongoing scrutiny from Washington.
全文請至原站閱讀。